scispace - formally typeset
Y

Yue Zhong Wu

Researcher at Ohio State University

Publications -  22
Citations -  5096

Yue Zhong Wu is an academic researcher from Ohio State University. The author has contributed to research in topics: DNA methylation & Restriction landmark genomic scanning. The author has an hindex of 19, co-authored 22 publications receiving 4774 citations. Previous affiliations of Yue Zhong Wu include Wake Forest University.

Papers
More filters
Journal ArticleDOI

Epigenetic differences arise during the lifetime of monozygotic twins

TL;DR: Older monozygous twins exhibited remarkable differences in their overall content and genomic distribution of 5-methylcytosine DNA and histone acetylation, affecting their gene-expression portrait, indicating how an appreciation of epigenetics is missing from the understanding of how different phenotypes can be originated from the same genotype.
Journal ArticleDOI

Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia

TL;DR: These results provide evidence that the mechanisms of Sp1/NFkappaB/HDAC/miR-29b-dependent KIT overexpression contribute to leukemia growth and can be successfully targeted by pharmacological disruption of the Sp1 /NFkappB/ HDAC complex or synthetic miR- 29b treatment in KIT-driven AML.
Journal ArticleDOI

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

TL;DR: This work developed a mouse model of T/natural killer acute lymphoblastic leukemia that is always preceded by polyclonal lymphocyte expansion to determine how aberrant promoter DNA methylation and consequent gene silencing might be contributing to leukemic transformation.
Journal ArticleDOI

Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome

TL;DR: Current methods of hESC propagation can rapidly programme stable and unpredictable epigenetic changes in the stem cell genome, which highlights the need for novel screening strategies and standardization of procedures for the derivation and culture of h ESC lines that minimize culture-induced instability.
Journal ArticleDOI

A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes

TL;DR: One novel amplicon is identified on chromosome 11q22, in addition to previously reported amplicons that include oncogenes MYCC, MYCL1 and previously identified amplification of chromosomal regions 6q21 and 3q26-27, which has been reported in other types of cancer.